Medication info
Telmiquore Tablets 40 mg (Telmisartan)

Telmiquore Tablets 40 mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tablet
Manufacturer / importer
Teragen Etex Co., Ltd.
Appearance
White oval-shaped tablet
Packaging
30 tablets (10 tablets/Alu-Alu × 3), 30 tablets/bottle
Approval status
Active

MFDS item code 201801338 · Approved 2018.03.27 · Insurance code 698503860

Summary

Main use
Treatment of essential hypertension; prevention of cardiovascular disease in high-risk patients
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Administer 40 mg of telmisartan orally once daily with water, with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This drug produces an additional blood pressure-lowering effect when administered in combination with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: Administration of 80 mg of this drug orally once daily with water is recommended; it may be taken with or without food. The effect on reducing the risk of cardiovascular morbidity and mortality at doses below 80 mg is unknown. When starting treatment with this drug to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive agents may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild to moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Teragen Etex Co., Ltd.

Efficacy & effects

Treatment of essential hypertension; prevention of cardiovascular disease in high-risk patients

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attack
  • clinical evidence of damage to distal organs in high-risk diabetes
View approved original text

This medication is used to control blood pressure in patients with essential hypertension. Additionally, it is effective in reducing the risk of death from myocardial infarction, stroke, and cardiovascular diseases in high-risk patients over the age of 55 who have a high risk of cardiovascular diseases such as coronary artery disease, peripheral artery disease, and stroke. Specifically, this medication can be used as an alternative treatment when ACE inhibitors cannot be used. Therefore, it aids in managing essential hypertension and reducing the risk of cardiovascular diseases.

How to take

Adult dose

1. Essential hypertension Adults: Administer 40 mg of telmisartan orally once daily with water, with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This drug produces an additional blood pressure-lowering effect when administered in combination with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: Administration of 80 mg of this drug orally once daily with water is recommended; it may be taken with or without food. The effect on reducing the risk of cardiovascular morbidity and mortality at doses below 80 mg is unknown. When starting treatment with this drug to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive agents may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild to moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication can cause serious harm to the fetus and newborn during pregnancy, so treatment should be discontinued immediately upon confirmation of pregnancy. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication. Patients with severe liver impairment or problems with bile excretion should also avoid this medication. Patients with hereditary angioedema or a history of angioedema should avoid this medication. Patients with moderate to severe kidney impairment among diabetes patients should not take this medication with certain other drugs. Patients with genetic disorders such as lactose intolerance should also avoid this medication. Elderly patients or those with high serum potassium levels or impaired liver function should use this medication with caution. Precautions are also necessary for patients with heart valve disease or related cardiovascular conditions. Excessive blood pressure lowering may increase the risk of myocardial infarction or stroke, so careful blood pressure management is advisable. Patients with kidney-related conditions or severe renal impairment should also be cautious as there is a risk of worsening kidney function when taking this medication. When used with other antihypertensives or specific medications, the risk of side effects may increase due to interactions, so consultation with a physician is recommended. This medication has a blood pressure-lowering effect, so any symptoms of hypotension should be reported immediately, and appropriate treatment should be received if necessary. Serious side effects such as liver dysfunction, angioedema, hyperkalemia, renal impairment, shock, interstitial pneumonia, and rhabdomyolysis may rarely occur, so any unusual symptoms should be reported to a physician immediately. This medication is contraindicated during pregnancy and should be avoided by nursing women. Safety in pediatric patients has not been established, thus it is recommended that individuals under 18 years should not take this medication. In cases of overdose, symptoms such as hypotension, dizziness, and acute renal failure may occur, so the dosage must be followed strictly, and immediate medical attention should be sought in case of overdose. This medication should be kept out of reach of children and stored sealed until just before administration. Caution should be taken while driving or operating machinery as fainting or dizziness may occur.

Side effects

  • Upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 121 more
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • dysgeusia
  • liver function abnormalities
  • liver disorder
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute renal failure
  • chest pain
  • weakness
  • influenza-like illness
  • elevated serum creatinine
  • increased serum uric acid
  • elevated liver enzymes
  • increased serum creatine kinase
  • decreased hemoglobin
  • weakness
  • hunger
  • cold sweat
  • hand tremors
  • decreased concentration
  • convulsions
  • altered consciousness
  • facial swelling
  • lip swelling
  • pharyngeal and laryngeal swelling
  • tongue swelling
  • laryngeal edema
  • severe hyperkalemia
  • renal failure
  • shock
  • loss of consciousness
  • jaundice
  • respiratory distress
  • hypotension
  • fever
  • pneumonia
  • myalgia
  • elevated creatine kinase
  • increased serum myoglobin
  • increased urinary myoglobin
  • palpitations
  • fatigue
  • nausea
  • inadequate effect
  • headache
  • dizziness
  • facial spasms
  • sensory disturbances
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • appetite loss
  • arrhythmia
  • weakness
  • edema
  • decreased libido
  • facial swelling
  • rash
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • headache
  • dizziness
  • myalgia
  • dermatitis
  • dizziness
  • dyspepsia
  • cough
  • abdominal pain
  • appetite loss
  • weakness
  • intestinal vascular edema
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea
  • hypotension
  • tachycardia
  • bradycardia
  • acute renal failure
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture and kept at room temperature between 1 degree and 30 degrees Celsius. Storing it this way helps maintain the effectiveness of the medication and prevents degradation.

Appearance and packaging

Appearance

White oval-shaped tablet

Package unit

30 tablets (10 tablets/Alu-Alu × 3), 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.